Optimizing Linezolid: Transforming It into a Selective MAO-B Inhibitor via a Toxicity-to-Activity Optimization Approach.
Dhangar MS, Ahmad I, Oh JM, Patil BR, Chinnam S, Sriram D, Kumari J, Mathew B, Sayyed RA, Chaudhari SB, Ansari SA, Rai N, Kim H, Patel HM.
Dhangar MS, et al.
ACS Med Chem Lett. 2024 Dec 16;16(1):40-50. doi: 10.1021/acsmedchemlett.4c00354. eCollection 2025 Jan 9.
ACS Med Chem Lett. 2024.
PMID: 39811132
Linezolid, a widely used oxazolidinone antibiotic, exhibits potent activity against resistant bacterial infections but is associated with serotonergic toxicity, primarily due to its inhibition of monoamine oxidase (MAO). MAOs, consisting of MAO-A and M …
Linezolid, a widely used oxazolidinone antibiotic, exhibits potent activity against resistant bacterial infections but is associated with se …